ArticleMediterranean journal of hematology and infectious diseases2019
Increase in
Article in Mediterranean journal of hematology and infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.
- Candida parapsilosis: A systematic review to inform the World Health Organization fungal priority pathogens list.Medical mycology · 2024Pooled it
- Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models.BMC infectious diseases · 2023Pooled it
- Pooled it
- We Are Family: Comparative Study ofPathogens (Basel, Switzerland) · 2026Article
- Clinical impact of fluconazole-resistantFuture microbiology · 2025Review
- Antimicrobial and antiparasitic potential of lupeol: antifungal effect on theJournal of medical microbiology · 2025Article
- A Case of Central Venous Catheter-RelatedMediterranean journal of hematology and infectious diseases · 2024Article
- Overview ofCurrent medical mycology · 2024Article
- Molecular diagnosis, phylogenetic analysis, and antifungal susceptibility profiles of Candida species isolated from neutropenic oncological patients.BMC infectious diseases · 2023Article
- Environmental Clonal Spread of Azole-ResistantJournal of fungi (Basel, Switzerland) · 2021Article
- Partridge and embryonated partridge egg as new preclinical models for candidiasis.Scientific reports · 2021Article
- Timing for Step-Down Therapy of Candidemia in Non-Neutropenic Patients: An International Multi-Center Study.Mediterranean journal of hematology and infectious diseases · 2021Article
- Candidemia in Patients with Acute Leukemia: Analysis of 7 Years' Experience at a Single Center in China.Mediterranean journal of hematology and infectious diseases · 2020Article
- Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of IranianFrontiers in cellular and infection microbiology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to identify the risk factors of candidemia and asses possible clinically significant differences between
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.